Home/ENA Respiratory/Christophe Demaison, PhD

CD

Christophe Demaison, PhD

CEO

ENA Respiratory

Therapeutic Areas

Respiratory Infectious Diseases Immunology

ENA Respiratory Pipeline

Drug	Indication	Phase
INNA-051	Prophylaxis against viral respiratory infections (e.g., SARS‑CoV‑2, influenza, rhinovirus)	Phase 2

Leadership Team at ENA Respiratory

Ruth Tal‑Singer, PhD

Medicine Development Leader

Courtney Crim, MD

Chief Medical Officer

View full ENA Respiratory profile